PRESS RELEASE published on 07/18/2024 at 18:21, 1 year 6 months ago Sartorius Stedim Biotech SA: Sartorius Stedim Biotech adjusts its guidance for fiscal year 2024 and presents results for H1 2024 Sartorius Stedim Biotech adjusts fiscal year 2024 guidance with positive sales trend in H1 2024 amid volatile market. Company's key financials and outlook disclosed Fiscal Year 2024 Sartorius Stedim Biotech Outlook Sales Trend Key Financial Indicators
BRIEF published on 07/02/2024 at 14:58, 1 year 6 months ago Number of shares and voting rights of Sartorius Stedim Biotech SA Share Capital Voting Rights Actions AMF Sartorius Stedim Biotech
PRESS RELEASE published on 07/02/2024 at 14:53, 1 year 6 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in the issued capital according to French regulations. Details in press release Voting Rights Shares French Regulations Sartorius Stedim Biotech SA Issued Capital
BRIEF published on 07/02/2024 at 11:30, 1 year 6 months ago Half-year review of the Sartorius Stedim Biotech liquidity contract Liquidity Kepler Cheuvreux AMF Transparency Sartorius
PRESS RELEASE published on 07/02/2024 at 11:27, 1 year 6 months ago Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech Sartorius Stedim Biotech's half-year liquidity contract statement reveals significant shares and volume on June 30th, 2024. The company is a key player in the biopharmaceutical industry with a global presence Liquidity Contract Shares Traded Volume Sartorius Stedim Biotech Biopharmaceutical Industry
PRESS RELEASE published on 07/02/2024 at 11:25, 1 year 6 months ago Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech Sartorius Stedim Biotech SA reports half-year liquidity contract statement with details on executed shares, traded volumes, and resources, following AMF Decision N°2021-01 Shares Traded Volume Sartorius Stedim Biotech AMF Decision Half-year Liquidity Contract
BRIEF published on 06/04/2024 at 10:15, 1 year 7 months ago Publication of the Number of Shares and Voting Rights of Sartorius Stedim Biotech SA Share Capital Voting Rights Actions AMF Sartorius Stedim Biotech
PRESS RELEASE published on 06/04/2024 at 10:10, 1 year 7 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights. The total number of shares is 97,330,405 with 165,579,822 total voting rights Voting Rights Shares Sartorius Stedim Biotech SA Issued Capital French Regulatory News
BRIEF published on 05/17/2024 at 19:37, 1 year 8 months ago Sartorius Stedim Biotech unveils its strategy at Capital Markets Day Business Strategy Webcast Sartorius Stedim Biotech Financial Forecast Capital Markets Day
PRESS RELEASE published on 05/17/2024 at 19:32, 1 year 8 months ago Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast Sartorius Stedim Biotech presented its business strategy and goals during Capital Markets Day, reaffirming its 2024 forecast and medium-term ambitions up to 2028. Links to presentation and webcast provided for broad access Business Strategy Webcast Forecast Sartorius Stedim Biotech Capital Markets Day
Published on 01/30/2026 at 22:45, 59 minutes ago Noram Lithium Announces Fully Allocated Non-Brokered Financing
Published on 01/30/2026 at 22:30, 1 hour 14 minutes ago Alta Copper Receives Court Approval for Proposed Acquisition by Fortescue
Published on 01/30/2026 at 14:00, 9 hours 44 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 15 hours 9 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 22:00, 1 hour 44 minutes ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 3 hours 34 minutes ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 3 hours 35 minutes ago Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 3 hours 37 minutes ago Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 17:45, 5 hours 59 minutes ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 1 day 5 hours ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 5 hours ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 5 hours ago Cegedim generated LFL revenue growth of 1.1% in 2025